Harmful waste products as novel immune modulators for treating inflammatory arthritis?
Cope
Andrew P
AP
Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London, United Kingdom. andrew.cope@imperial.ac.uk
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D017382:Reactive Oxygen Species / Q000627:therapeutic use; D016897:Respiratory Burst / Q000276:immunology
D007155:Immunologic Factors; D017382:Reactive Oxygen Species